Proton pump inhibitor influence on reflux in Barrett's oesophagus

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 9, 2008, Pages 881-887

  Smythe, Anne ^a   Troy, Gill P ^a   Ackroyd, Roger ^a   Bird, Nigel C ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Proton pump inhibitors; Reflux

Indexed keywords

ACID; ANTIMONY; BASE; OMEPRAZOLE; SODIUM ION; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CATHETER; CONTROLLED STUDY; DUODENOGASTROESOPHAGEAL REFLUX; ELECTRODE; ESOPHAGUS MOTILITY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PERISTALSIS; PH; PRESSURE TRANSDUCER; PRIORITY JOURNAL; STANDING; STIMULATION; SUPINE POSITION; BODY POSTURE; CLINICAL TRIAL; DRUG EFFECT; DUODENOGASTRIC REFLUX; ESOPHAGEAL PH MONITORING; ESOPHAGUS; MANOMETRY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; BARRETT ESOPHAGUS; DUODENOGASTRIC REFLUX; ESOPHAGEAL PH MONITORING; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MANOMETRY; MIDDLE AGED; PERISTALSIS; POSTURE; PROTON PUMP INHIBITORS; YOUNG ADULT;

EID: 58149296280     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f9b221     Document Type: Article

References (34)

1. Barrett NR. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg 1950; 38:175-182.
2. Prach AT, Mcdonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet 1997; 350:933.
3. Blot WJ, Devesa SS, Kneller RW, Fraunmeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 1991; 265:1287-1289.
4. Van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett's oesophagus in the general population. Gut 2005; 54:1062-1066.
5. Rodriguez Garcia LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006; 55:1538-1544.
6. Parrilla P, Oritz A, Martinez de Haro L, Aguayo J, Ramirez P. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus. Gut 1990; 31:964-967.
7. Sharma P, Sampliner RE, Camargo E. Normalisation of esophageal pH with high dose proton pump inhibitor therapy does not result in regression of Barrett's oesophagus. qAm J Gastroenterol 1997; 92:582-585.
8. Wetscher GJ, Profanter C, Gadenstatter M, Perdikis G, Glaser K, Hinder R. Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor oesophageal body motility. Langenbeck's Arch Chir 1997; 382:95-99.
9. Adamek RJ, Wegener M, Wienbeck M, Gielen B. Long-term esophageal manometry in healthy subjects. Evaluation of normal values and influence of age. Dig Dis Sci 1994; 39:2069-2073.
10. Corey KE, Schmitz S, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrettt's esophagus? A meta-analysis. Am J Gastroenterol 2003; 98:2390-2394.
11. Bumm R, Feussner H, Holscher A, Jorg K, Dittler H, Siewert J. Interaction of gastroesophageal reflux and esophageal motility. Dig Dis Sci 1992; 37:1192-1199.
12. Anggiansah A, Taylor G, Marshall R, Bright N, Owen WA, Owen WJ. Oesophageal motor responses to gastro-oesophageal reflux in healthy controls and reflux patients. Gut 1997; 41:600-605.
13. Smythe A, Bird N, Troy GP, Johnson AG. In Barrett's oesophagus patients, reduction in acid reflux is linked to improved oesophageal motility when a prokinetic is added to a PPI. Neurogastroenterol Motil 2001; 13:432.
14. Harmon JW, Johnson LF, Maydonovitch CL. Effects of acid and bile salts on the rabbit esophageal mucosa. Dig Dis Sci 1981; 26:65-72.
15. Vaezi MF, Richter JE. Twenty-four-hour ambulatory esophageal pH monitoring in the diagnosis of acid reflux-related chronic cough. South Med J 1997; 90:305-311.
16. Sarela A, Hicks D, Verbeke C, Casey J, Guillou P, Clark G. Persistent acid and bile reflux in asymptomatic patients with Barrett's esophagus receiving proton pump inhibitor therapy. Arch Surg 2004; 139:547-551.
17. Byrne PJ, Mulligan ED, O'Riordan J, Keeling PW, Reynolds JV. Impaired visceral sensitivity to acid reflux in patients with Barrett's esophagus. The role of esophageal motility. Dis oesophag 2003; 16:199-203.
18. Smythe A, O'Leary D, Johnson A. Duodenogastric reflux after gastric surgery and in gastric ulcer disease: continuous measurement with a sodium ion selective electrode. Gut 1993; 34:1047-1050.
19. Champion G, Richter JE, Vaezi RJ, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's oesophagus. Gastroenterol 1994; 107:747-754.
20. Marshall RE, Anggiansah A, Manifold DK, Owen WA, Owen WJ. Effect of omeprazole 20mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus. Gut 1998; 43:603-606.
21. Todd J, Basu AK, De Caestecker J. Normalization of oesophageal pH does not guarantee control of duodeno-oesophageal reflux in Barrett's oesophagus. Aliment Pharmacol Ther 2005; 21:969-975.
22. Murray JA, Clouse R, Conclin JL. Components of the standard oesophageal manometry. Neurogastroenterol Motil 2003; 15:591-606.
23. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dyfunction on oesophageal volume clearance. Gastroenterol 1998; 94:73-80.
24. Netzer P, Gut A, Brundler R, Gaila C, Halter F, Inauen W. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. qAliment Pharmacol Ther 2001; 15: 1375-1384.
25. McDougal N, Mooney R, Ferguson W, Collins J, McFarland R, Love A. The effect of healing oesophagitis on oesophageal motor function as determined by oesophageal scintigraphy and ambulatory oesopageal motility/pH monotoring. Aliment Pharmacol Ther 1998; 12:899-907.
26. Deprez P, Fiasse R. Healing of severe esophagitis improves esophageal peristaltic dysfunction. Dig Dis Sci 1999; 44:125-133.
27. Niemantsverdriet E, Timmer R, Breumelhof R, Smout A. The roles of excessive gastro-oesophageal reflux, disordered oesophageal motility and decreased mucosal sensitivity in the pathogenesis of Barrett's oesophagus. Eur J Gastroenterol Hepatol 1997; 9:515-519.
28. Fouad Y, Katz P, Castell D. Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors. Aliment Pharmacol Ther 1999; 13:1467-1471.
29. Mahon D, Rhodes M, Decadt B, Hindmarsh A, Lowndes R, Beckingham I, et al. Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton pump inhibitorsfor treatment of chronic gastrooesophageal reflux. Br J Surg 2005; 92:695-699.
30. Bremmer RM, Richter JE, De Meester TR, Peters JH, Stein HJ. Concentration of refluxed acid and esophageal mucosal injury. Am J Surg 1992; 164:522-527.
31. Stein H, Demeester TR. Functional foregut abnormalities in Barrett's oesophagus. J Thorac Cardiovasc Surg 1993; 105:107-111.
32. Castell DO, Katza DA. Importance of adequate acid suppression in the management of Barrett's oesophagus. Gastroenterology 1999; 117: 1509-1510.
33. Gerson L, Boparai V, Ullah N, Triadafilopoulos A. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors. Aliment Pharmacol Ther 2004; 20:637-643.
34. Oritz A, Martinez de Haro LF, Parrilla P, Molins J, Bermejo J, Munitiz V. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors. Br J Surg 1999; 86:1472-1476.